Patents by Inventor Anthony SALEH

Anthony SALEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240141346
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Application
    Filed: August 25, 2023
    Publication date: May 2, 2024
    Inventors: Robert PLACE, Anthony SALEH, Tishan WILLIAMS
  • Patent number: 11795459
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: October 24, 2023
    Assignee: MIRECULE, INC.
    Inventors: Robert Place, Anthony Saleh, Tishan Williams
  • Publication number: 20230295626
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Application
    Filed: January 17, 2023
    Publication date: September 21, 2023
    Inventors: Robert PLACE, Anthony SALEH, Tishan WILLIAMS
  • Publication number: 20230132602
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Application
    Filed: April 2, 2021
    Publication date: May 4, 2023
    Inventors: Robert PLACE, Anthony SALEH, Tishan WILLIAMS
  • Patent number: 11597930
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: March 7, 2023
    Assignee: MIRECULE, INC.
    Inventors: Robert Place, Anthony Saleh, Tishan Williams
  • Publication number: 20220213480
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Application
    Filed: March 11, 2022
    Publication date: July 7, 2022
    Inventors: Robert PLACE, Anthony SALEH, Tishan WILLIAMS
  • Publication number: 20220213481
    Abstract: Disclosed herein are engineered oligonucleotides for selective inhibition of polypeptide expression and activity. Also disclosed herein are methods of selectively inhibiting polypeptide expression and activity contacting an engineered oligonucleotide with a polynucleotide encoding the polypeptide.
    Type: Application
    Filed: March 11, 2022
    Publication date: July 7, 2022
    Inventors: Robert PLACE, Anthony SALEH, Tishan WILLIAMS